Diabetes Market Research Reports & Industry Analysis

The notion “diabetes” refers to a disease impacting the body’s ability to produce/use insulin. At present, more than 365 million people suffer from the disease worldwide. By 2030, the figure may reach 550 million. Inappropriate eating habits combined with a sedentary lifestyle, growth of the diabetic population and an increase in the number of obesity cases are amid the main factors contributing to the diabetes market growth. The list of the products available on the market is extensive: continuous blood glucose meters, anti-diabetic drugs, insulin and insulin pumps, artificial pancreas devices, etc.

Evaluated at over USD 19.8 billion, North America represents the top market, while Europe acts as the second largest player. The global diabetes market is expected to be at approximately USD 100 billion in 2018, showing a twofold increase if compared to 2011.

The Catalogue includes research reports dedicated to the diabetes market. The studies describe past and current industry trends, disclose data on the market competition and profile top industry behemoths. Information on the upcoming market events, industry growth drivers and hindrances can be found in the reports, too. Besides, the research reports contain evaluation of the actual economic situation, analyses of the market prospects.

Found 129 publications
India Diabetes Market Report 2017 US$ 2,350.00

... still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 ... ) Channel (Direct Sales, Distributor) Segmentation Section 7: 400 USD - Trend (2017-2021) Section 8: 300 USD - Product Type Detail Section 9: 700 ...

Dec, 2017 126 pages
Medical Affairs Reputations: Type 2 Diabetes Mellitus (US) US$ 6,175.00

Find out what the leading medical affairs teams in type 2 diabetes are doing right Medical affairs teams for several leading T2DM treatments in the US ... your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (US). Comparing 11 major melanoma treatments from ...

Jul, 2017
Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5) US$ 6,175.00

... what your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5). Comparing 7 major melanoma treatments from Novo ...

Jul, 2017
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes US$ 4,995.00

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape ... the diversifying and highly lucrative diabetes mellitus (DM) market. Analysis has identified a high level of ... review of products, segmented by stage of development, molecule type and molecular target - as well as detailed profile assessments ...

Sep, 2017 137 pages
Gestational Diabetes Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Aug, 2017 133 pages
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 US$ 2,500.00

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report ...

Aug, 2017 283 pages
Diabetic Retinopathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 244 pages
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 126 pages
Diabetic Neuropathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 249 pages
Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 122 pages
Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Jul, 2017 49 pages
Diabetic Nephropathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 317 pages
Diabetic Macular Edema Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Jul, 2017 316 pages
Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 48 pages
Diabetic Gastroparesis Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 65 pages
Diabetic Foot Ulcers Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Jul, 2017 179 pages
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 62 pages
Diabetes Insipidus Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 45 pages
Diabetic Gastroparesis Forecast in 12 Major Markets 2017-2027 US$ 6,150.00

... also included at a country level across the 10-year forecast snapshot. These gastrointestinal symptoms include: Nausea ... impact from specific co-morbid conditions on Diabetic Gastroparesis prevalent population. Identify sub-populations within Diabetic Gastroparesis which require treatment. Gain an understanding ...

Apr, 2017 50 pages
Indian Diabetes Market Research and Analysis, 2015-2022 US$ 3,495.00 US$ 2,796.00

... India, Pfizer India, Sanofi Aventis, Sun Pharmaceuticals, USV India. Market Segments 1. INDIAN DIABETES MARKET BY TYPE 2. INDIAN DIABETES MARKET BY DRUG CLASS 3. INDIAN DIABETES MARKET BY DEVICES OMR REPORT COVERS: Comprehensive research methodology of Global Indian Diabetes Market ...

May, 2017
The 2018-2023 World Outlook for Diabetic Macular Edema (DME) Treatments US$ 995.00

This study covers the world outlook for diabetic macular edema (DME) treatments across more than ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... (DME) treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...

Apr, 2017 300 pages
The 2018-2023 World Outlook for Diabetic Food US$ 995.00

This study covers the world outlook for diabetic food across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... diabetic food. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...

Apr, 2017 292 pages
The 2018-2023 World Outlook for Diabetes Therapeutics and Diagnostics US$ 995.00

This study covers the world outlook for diabetes therapeutics and diagnostics across more than 190 ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 296 pages
The 2018-2023 World Outlook for Diabetes Monitoring, Treatment, and Drug Delivery Products US$ 995.00

This study covers the world outlook for diabetes monitoring, treatment, and drug delivery products across ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 310 pages
The 2018-2023 World Outlook for Diabetes Drugs US$ 995.00

This study covers the world outlook for diabetes drugs across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... diabetes drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...

Apr, 2017 292 pages
The 2018-2023 World Outlook for Diabetes Diagnostics US$ 995.00

This study covers the world outlook for diabetes diagnostics across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Diabetes Diagnosis, Treatment, and Drug Delivery Devices US$ 995.00

This study covers the world outlook for diabetes diagnosis, treatment, and drug delivery devices across ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 310 pages
The 2018-2023 World Outlook for Diabetes Devices and Drugs US$ 995.00

This study covers the world outlook for diabetes devices and drugs across more than 190 ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... and drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Diabetes Devices US$ 995.00

This study covers the world outlook for diabetes devices across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... diabetes devices. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Diabetes Care Devices US$ 995.00

This study covers the world outlook for diabetes care devices across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
Type 1 Diabetes Mellitus Forecast in 12 Major Markets 2017-2027 US$ 6,150.00

... at a country level across the 10-year forecast snapshot. There are many co-morbidities associated with Type 1 Diabetes Mellitus, including: Chronic pancreatitis Cystic fibrosis Autoimmune ... on the impact from specific co-morbid conditions on Type 1 Diabetes Mellitus prevalent population. Identify sub-populations within Type 1 Diabetes Mellitus which require treatment. Gain an understanding of the ...

Mar, 2017 54 pages
OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 US$ 10,995.00

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 SUMMARY GlobalData estimates sales of diabetic foot ulcer (DFU) and diabetic foot infection (DFI) drugs to be approximately $292.1M across the ... most lucrative within the DFU space? Key Findings Prevalence of diabetes and resulting DFUs, DFIs are increasing across the 7MM ...

Dec, 2016 166 pages
Global Diabetes Market: Industry Analysis & Outlook (2016-2020) US$ 800.00

... be seen during pregnancy. The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth drivers as well ... are being profiled. The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing healthcare expenditure ...

Dec, 2016 107 pages
Global Diabetes Market Research and Analysis, 2014-2020 US$ 3,495.00 US$ 2,796.00

Market Insight Global Diabetes Market is expected to grow at a CAGR of 8.1 percent for the forecasted period of 2015-2020. The market is segmented on the basis of type of diabetes, drugs class and ...

May, 2016 140 pages
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 US$ 10,995.00

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 SUMMARY While ... ’ efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded ...

Jul, 2017 377 pages
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth US$ 4,995.00

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth SUMMARY Diabetes mellitus ... range of treatment options, including biguanide (metformin), sulfonylureas, thiazolidinediones, GLP-1 receptor ...

Oct, 2017 202 pages
Global Diabetic Food Market Report 2016 US$ 2,850.00

2016 Global Diabetic Food Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetic Food industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetic Food industry; 3.) the North American Diabetic Food industry; 4.) the European Diabetic Food industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 146 pages
Global Diabetes Management Market Report 2016 US$ 2,850.00

2016 Global Diabetes Management Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetes Management industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetes Management industry; 3.) the North American Diabetes Management industry; 4.) the European Diabetes Management industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 146 pages
Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies US$ 6,995.00

Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies Summary Diabetes is a common long-term condition that can ...

Jun, 2016 73 pages
Diabetic Nephropathy Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016' provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial ...

May, 2016 309 pages
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016 US$ 2,500.00

... clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016' provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI ...

May, 2016 58 pages
Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor (CGM) And Test Strips)), Delivery Type... US$ 4,950.00

... delivery devices segment. The global diabetes devices market is expected to reach USD 35.4 billion in 2024. The monitoring and diagnostic devices segment captured the largest market share of the overall market in 2015 ...

May, 2016 81 pages
US Diabetes Market Report: 2016 - 2020 US$ 1,200.00

... report “US Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the US diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States ...

May, 2016 44 pages
UK Diabetes Market Report: 2017 - 2022 US$ 1,200.00

IMARC’s new report “UK Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the ... , market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing ...

Feb, 2017 50 pages
Spain Diabetes Market Report: 2017 - 2022 US$ 1,200.00

IMARC’s new report “Spain Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the Spain diabetes market. The report provides both current and future trends in the ... planning to foray into the Spain diabetes market in any form. What we have achieved in this report: Comprehensive situation analysis of the Spain diabetes epidemiology and its dynamics ...

Feb, 2017 51 pages
Germany Diabetes Market Report: 2017 - 2022 US$ 1,500.00

IMARC’s new report “Germany Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the Germany diabetes market. The report provides both current and future trends in the ... planning to foray into the Germany diabetes market in any form. What we have achieved in this report: Comprehensive situation analysis of the Germany diabetes epidemiology and its dynamics ...

Feb, 2017 51 pages
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016 US$ 2,500.00

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials ...

Apr, 2016 270 pages
Global Type 2 Diabetes Market 2016-2020 US$ 2,500.00 US$ 2,250.00

... treat type 2 diabetes. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Type 2 Diabetes Market 2016- ... 2020, has been prepared based on an in-depth market analysis with inputs from ...

Mar, 2016 122 pages
NPS+ Type 2 Diabetes Mellitus [2017] US US$ 2,575.00

... how does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (US) gives a unique insight into the overall brand health of ... (liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (US) offers valuable insight into brand loyalty from the ...

Sep, 2017
NPS+ Type 2 Diabetes Mellitus [2017] EU5 US$ 2,575.00

... does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (EU5) gives a unique insight into the overall brand health ... degludec/liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (EU5) offers valuable insight into brand loyalty from ...

Sep, 2017
1 2 3 >
Skip to top